Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $45 at Needham
Tweet
Share
E-mailGet Alerts HRMY Hot Sheet
Price: $38.12 -0.99%
Rating Summary:
10 Buy, 4 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 9
Rating Summary:
10 Buy, 4 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 9
Join SI Premium – FREE
Needham analyst Ami Fadia raised the price target on Harmony Biosciences Holdings Inc. (NASDAQ: HRMY) to $45.00 (from $44.00) while maintaining a Buy rating.
You May Also Be Interested In
- Berenberg Upgrades Accelleron Industries AG (ACLN:SW) to Buy
- Danske Bank A/S (DANSKE:DC) (DNKEY) PT Raised to DKK340 at JPMorgan
- NKT A/S (NKT:DC) PT Lowered to DKK916 at Barclays
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
